No Data
No Data
Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus
Leerink Partners Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $169
Johnson & Johnson Pivots Its AI Strategy -- WSJ
Johnson & Johnson Options Spot-On: On April 17th, 82,557 Contracts Were Traded, With 535.06K Open Interest
UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com
$JNJ Stock Is up 2% Today. Here's What We See in Our Data.
loading...